Compare TNGX & BXMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TNGX | BXMT |
|---|---|---|
| Founded | 2014 | 1966 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 3.0B |
| IPO Year | 2020 | 1998 |
| Metric | TNGX | BXMT |
|---|---|---|
| Price | $20.23 | $18.35 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 5 |
| Target Price | ★ $21.78 | $21.38 |
| AVG Volume (30 Days) | ★ 2.5M | 1.3M |
| Earning Date | 05-08-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 9.85% |
| EPS Growth | 26.89 | ★ 154.70 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $62,384,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 48.29 | N/A |
| 52 Week Low | $3.77 | $17.67 |
| 52 Week High | $28.41 | $20.67 |
| Indicator | TNGX | BXMT |
|---|---|---|
| Relative Strength Index (RSI) | 42.30 | 46.65 |
| Support Level | $6.77 | $17.98 |
| Resistance Level | $22.01 | $18.96 |
| Average True Range (ATR) | 1.47 | 0.32 |
| MACD | -0.06 | 0.05 |
| Stochastic Oscillator | 6.95 | 66.13 |
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
Blackstone Mortgage Trust Inc is an externally managed real estate finance company that originates, acquires, and manages senior loans and other debt or credit-oriented investments collateralized by or relating to commercial real estate in North America, Europe, and Australia. Its portfolio is composed of senior loans secured by high-quality, institutional assets located in main markets, and sponsored by experienced, well-capitalized real estate investment owners and operators. The group finances its investments in a variety of ways, including borrowing under secured credit facilities, issuing collateralized loan obligations, or CLOs, other securitization transactions, syndicating senior loans and/or participations, and other forms of asset-level financing.